Targeting proprotein convertase subtilisin/kexin type 7 in macrophages as a therapeutic strategy to mitigate...

Area of Science:

• Cardiovascular Biology
• Immunology
• Molecular Medicine

Background:

• Myocardial infarction (MI), a severe form of coronary artery disease (CAD), causes significant heart inflammation and damage.
• Existing treatments for MI are insufficient, necessitating deeper understanding of immune cell roles in cardiac pathology.
• Proprotein convertase subtilisin/kexin type 7 (PCSK7) is linked to cardiovascular disease, but its function in cardiac immune cells is unclear.

Purpose of the Study:

• To investigate the role of PCSK7 in the inflammatory response following myocardial infarction (MI).
• To determine how PCSK7 influences immune cell behavior and cardiac function post-MI.

Main Methods:

• Utilized a mouse model of myocardial infarction (MI).
• Assessed the impact of PCSK7 deficiency on cardiac function, inflammation, and immune cell infiltration.
• Analyzed macrophage activation, lipid uptake, and intracellular signaling pathways (TNF-α/JNK) in response to PCSK7 modulation.

Main Results:

• PCSK7 deficiency led to reduced circulating cholesterol levels, mitigating infarct injury and improving cardiac function.
• PCSK7 was found to promote macrophage activation and lipid uptake in the ischemic cardiac tissue, exacerbating pathology.
• PCSK7 activates the TNF-α/JNK signaling pathway within macrophages, amplifying the inflammatory cascade.

Conclusions:

• PCSK7 plays a critical role in exacerbating post-MI inflammation by activating macrophages and promoting lipid uptake.
• Targeting PCSK7, particularly within macrophages, presents a potential therapeutic strategy to reduce inflammation and improve outcomes in myocardial infarction and CAD patients.